TW200611697A - Generally linear effervescent oral fentanyl dosage form and methods of administering - Google Patents

Generally linear effervescent oral fentanyl dosage form and methods of administering

Info

Publication number
TW200611697A
TW200611697A TW094107160A TW94107160A TW200611697A TW 200611697 A TW200611697 A TW 200611697A TW 094107160 A TW094107160 A TW 094107160A TW 94107160 A TW94107160 A TW 94107160A TW 200611697 A TW200611697 A TW 200611697A
Authority
TW
Taiwan
Prior art keywords
methods
administering
dosage form
generally linear
effervescent oral
Prior art date
Application number
TW094107160A
Other languages
Chinese (zh)
Other versions
TWI387466B (en
Inventor
Derek Moe
Vikas Agarwal
Walid Habib
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48471142&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200611697(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/026,132 external-priority patent/US7862832B2/en
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of TW200611697A publication Critical patent/TW200611697A/en
Application granted granted Critical
Publication of TWI387466B publication Critical patent/TWI387466B/en

Links

Classifications

    • Y02W90/11—

Abstract

Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.
TW94107160A 2004-10-04 2005-03-09 Generally linear effervescent oral fentanyl dosage form and methods of administering TWI387466B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61566504P 2004-10-04 2004-10-04
US11/026,132 US7862832B2 (en) 2003-12-31 2004-12-30 Generally linear effervescent oral fentanyl dosage form and methods of administering
US11/026,327 US20050142197A1 (en) 2003-12-31 2004-12-30 Generally linear effervescent oral fentanyl dosage form and methods of administering

Publications (2)

Publication Number Publication Date
TW200611697A true TW200611697A (en) 2006-04-16
TWI387466B TWI387466B (en) 2013-03-01

Family

ID=48471142

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94107160A TWI387466B (en) 2004-10-04 2005-03-09 Generally linear effervescent oral fentanyl dosage form and methods of administering

Country Status (2)

Country Link
AR (1) AR098347A2 (en)
TW (1) TWI387466B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US7862833B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
US7862832B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US8728441B2 (en) 1998-03-27 2014-05-20 Cephalon, Inc. Sublingual buccal effervescent
US8802130B2 (en) 1998-03-27 2014-08-12 Cephalon, Inc. Sublingual buccal effervescent

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8728441B2 (en) 1998-03-27 2014-05-20 Cephalon, Inc. Sublingual buccal effervescent
US8765100B2 (en) 1998-03-27 2014-07-01 Cephalon, Inc. Transmucosal effervescent
US8802130B2 (en) 1998-03-27 2014-08-12 Cephalon, Inc. Sublingual buccal effervescent
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US7862833B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
US7862832B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US8092832B2 (en) 2003-12-31 2012-01-10 Cephalon, Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US8119158B2 (en) 2003-12-31 2012-02-21 Cephalon, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US8298577B2 (en) 2003-12-31 2012-10-30 Cephalon, Inc. Effervescent oral opiate dosage forms and methods of administering opiates

Also Published As

Publication number Publication date
TWI387466B (en) 2013-03-01
AR098347A2 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
HK1100480A1 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
EP1708685A4 (en) Effervescent oral opiate dosage forms and methods of administering opiates
NO20062504L (en) Compositions and dosage forms for improved absorption
CY1118179T1 (en) PHARMACEUTICAL COMPOSITION
SI1730147T1 (en) SUBSTITUTED 1,4,8-TRIAZASPIRO?á4,5?åDECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
CO5640120A2 (en) FORMULATION AND METHODS FOR THE TROMBOCITEMIA TREATMENT
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
WO2009088673A3 (en) Pharmaceutical composition
IL179177A (en) Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition
DE60329968D1 (en) Dosage forms containing thyroid hormones and their method of preparation
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
TW200611696A (en) Effervescent oral fentanyl dosage form and methods of administering fentanyl
MY141008A (en) Oral formulations of deoxypeganine and their uses
SE0203817D0 (en) New composition
TW200611686A (en) Effervescent oral opiate dosage forms and methods of administering opiates
GB0201607D0 (en) Formulation for the administration of medicinal substances
SI1708686T1 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
GB0317345D0 (en) Formulation for the administration of medicinal substances
TW200722080A (en) Dosing regimen
AR048000A1 (en) SUBSTANTIALLY LINEAR EFERVESCENT ORAL DOSAGE FORM OF FENTANIL AND METHODS OF ADMINISTRATION
GB0219421D0 (en) Improvements in or relating to formulations for the delivery of drugs